Success has been at best very limited.
My personal opinion is that 30 years of mRNA research for beneficial use in cancer treatments has failed to yield a return on investment. As a result an alternative revenue stream for drugs to be produced instead is in vaccine applications which will be enormously profitable and recover those losses.
Look at animal experiments of breast cancer in animals on diets low in omega 6 fats. They don’t get cancer.